TRCT
IMCR icon

Tower Research Capital (TRC)’s Immunocore IMCR Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.4K Buy
1,177
+739
+169% +$21.9K ﹤0.01% 2979
2026
Q1 		$13.2K Sell
438
-1,435
-77% -$46.4K ﹤0.01% 3755
2025
Q4 		$65K Buy
1,873
+1,502
+405% +$53K ﹤0.01% 2236
2025
Q3 		$13.5K Buy
+371
New +$12.6K ﹤0.01% 3675
2025
Q2 		– Sell
-2,086
Closed -$61.9K – 5410
2025
Q1 		$61.9K Buy
2,086
+1,400
+204% +$42K ﹤0.01% 2077
2024
Q4 		$20.2K Sell
686
-276
-29% -$8.73K ﹤0.01% 3174
2024
Q3 		$29.9K Sell
962
-20,588
-96% -$749K ﹤0.01% 3008
2024
Q2 		$730K Buy
21,550
+20,515
+1,982% +$1.05M 0.01% 1015
2024
Q1 		$67.3K Buy
1,035
+724
+233% +$49.7K ﹤0.01% 2083
2023
Q4 		$21.2K Sell
311
-3,077
-91% -$160K ﹤0.01% 3609
2023
Q3 		$176K Buy
3,388
+820
+32% +$48.5K 0.01% 1522
2023
Q2 		$154K Sell
2,568
-3,820
-60% -$218K 0.01% 1734
2023
Q1 		$316K Buy
6,388
+4,147
+185% +$233K 0.01% 1111
2022
Q4 		$128K Sell
2,241
-904
-29% -$50.9K 0.01% 1635
2022
Q3 		$148K Buy
3,145
+2,860
+1,004% +$136K ﹤0.01% 2206
2022
Q2 		$11K Buy
+285
New +$9.26K ﹤0.01% 4375
2022
Q1 		– Sell
-19
Closed -$1K – 6302
2021
Q4 		$1K Buy
+19
New +$688 ﹤0.01% 5835

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Tower Research Capital (TRC)'s IMCR Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Immunocore (IMCR) stake by 169% in Q2 2026, buying an estimated $21.9K and bringing the position to 1,177 shares worth $37.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

Tower Research Capital (TRC) first reported a position in IMCR in Q4 2021 and has held it in 17 quarters since. The position peaked at $730K in Q2 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Tower Research Capital (TRC) held 1,177 shares of Immunocore worth $37.4K as of Q2 2026.
  • Tower Research Capital (TRC) bought 739 Immunocore shares in Q2 2026, an estimated $21.9K.
  • Immunocore made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2979 holding.
  • Tower Research Capital (TRC) first reported a position in Immunocore in Q4 2021 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Immunocore position peaked at $730K in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.